METALYSE 40MG INJECTION

METALYSE 40MG INJECTION belongs to the class of drugs called thrombolytics (clot-busting drugs) indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). Heart attack refers to blocked blood flow to the heart due to blockage of arteries. STEMI is a type of serious heart attack that mainly affects the lower chambers of the heart.

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug that helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack.

METALYSE 40MG INJECTION will be administered by a healthcare professional; do not self-administer. METALYSE 40MG INJECTION may cause common side effects such as bleeding, nosebleeds, bruising, bleeding at the injection or puncture site, or blood in the urine. If you notice such side effects, please inform your doctor.

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. 

METALYSE 40MG INJECTION contains Tenecteplase, a clot-busting drug indicated to reduce the risk of death in people who have had a serious type of heart attack known as acute ST-elevation myocardial infarction (STEMI). It helps to dissolve unwanted blood clots in the blood vessels of the heart. Thus, it helps to prevent damage caused by heart attack and has been shown to save lives.

• Bleeding
• Nosebleeds
• Bruising
• Bleeding at the injection or puncture site
• Blood in urine

If you are allergic to Tenecteplase or any other medicines, please tell your doctor. METALYSE 40MG INJECTION should be used with caution in patients aged over 75 years of age and who weigh less than 60 kg. METALYSE 40MG INJECTION is not recommended for children below 18 years of age as the safety and effectiveness were not established. If you are a pregnant or breastfeeding woman, please inform your doctor before receiving METALYSE 40MG INJECTION. If you have had a recent major surgery or trauma, inform your doctor. METALYSE 40MG INJECTION is not recommended if you have been given cardiopulmonary resuscitation (chest compressions) for more than 2 minutes duration in the last two weeks. You are advised to be careful while using sharp objects, cutting nails, or shaving, as METALYSE 40MG INJECTION may increase the risk of bleeding. 

• Maintain a diet consisting of vegetables, whole grains, fruits and lean protein.
• Reduce sugar and processed foods.
• Include foods high in antioxidants, such as vegetables, fruits, olive oil, seeds, nuts, cocoa, and red wine, as they may lower the risk of developing blood clots.
• Adopt an anti-inflammatory diet high in omega-3-rich foods, fruits and vegetables, and vitamin-E-rich foods.
• Drink plenty of fluids as dehydration can thicken blood leading to an increased risk of blood clot formation.
• Do regular exercise as it helps to dissolve blood clots, especially in obese people.
• Quit smoking and also avoid being around secondhand smoke.